Atlas Trials

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Clinical trial NCT00485719 · COMPLETED

Trial details

NCT number
NCT00485719
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2007-06-01
Primary completion
2012-09-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.